The October 2017 meeting of the WTO TRIPS Council witnessed heated discussions on compulsory licensing within the context of IP and the Public Interest. As reported earlier by Knowledge Ecology International, on 31 May 2017, Brazil, China, Fiji, India, and… Continue Reading
https://www.keionline.org/?s=injunction Selected U.S. Patent Injunction Cases 2017. Wisconsin Alumni Research Foundation v. APPLE, INC., Dist. Court, WD Wisconsin 2017 At the end of the day, the court concludes that WARF has not met its burden of demonstrating irreparable harm, and… Continue Reading
Some key events in the early development of the proposal for a Pan African Intellectual Property Organization Joelle Dountio 10 February 2013 Feb 2003. The Secretariat of the New Partnership for Africa’s Development (NEPAD), which is a program of the… Continue Reading
To be added, the early CLs on HIV drugs in several African countries. South Africa 2013 2003: CPTech’s 2003 reports for the RSA Competition Commission, in Hazel Tau et al.v GSK, Boehringer, et al. CPTech was the consultant to the… Continue Reading
India 2010 2010: India’s intervention to the WTO TRIPS Council: TRIPS plus enforcement trends, 2010-06-10 2011 2011: Karl De Gucht writes Andris Piebalgs on topic of European Union IPR demands on India and other developing countries, 2011-05-28 2011: WTO TRIPS… Continue Reading
Brazil 1990-2000 Comments for the Working Group On Intellectual Property Rights, Third Trade Ministerial and Americas Business Forum, Belo Horizonte, Brazil, May 13-16,1997, 1997-05-16 2005 U.S. DoS Cable: U.S. PHARMA FIRMS THREATENED WITH LICENSING (Brazil), June 3, 2005. U.S. DoS… Continue Reading
EU For an earlier survey, see: 2014:1 KEI Research Note: Recent European Union Compulsory Licenses. 2014-03-01 DG-Enterprise – data exclusivity prevents access to life saving drugs (in the EU), even in an emergency situation, 2012-07-31 Germany German Court Issues Compulsory… Continue Reading
2008 Colombian Submission to the WHO IGWG negotiation, 2008-03-07 2015 Switzerland pressures Colombia to deny compulsory license on imatinib, 2015-08-17 2016 Colombia takes an important step in defining the public interest in compulsory licensing case, 2016-03-04 Colombia Technical Committee Recommends… Continue Reading